Evidence map›Paper›PMID 31317187›Full record

ArticleInternational journal of epidemiology2019

The long-term rapid increase in incidence of adenocarcinoma of the kidney in the USA, especially among younger ages.

Tongzhang Zheng, Cairong Zhu, Bryan A Bassig, Simin Liu, Stephen Buka, Xichi Zhang, Ashley Truong, Junhi Oh, John Fulton, Min Dai and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in International journal of epidemiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

Tongzhang ZhengBrown School of Public Health, Providence, RI, USA.
Cairong ZhuDepartment of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
Bryan A BassigDivision of Cancer Epidemiology and Genetics, NCI, Bethesda, MD, USA.
Simin LiuBrown School of Public Health, Providence, RI, USA.
Stephen BukaBrown School of Public Health, Providence, RI, USA.
Xichi ZhangGeorge Washington University, Washington, DC, USA.
Ashley TruongBrown School of Public Health, Providence, RI, USA.
Junhi OhRhode Island Department of Health, Providence, RI, USA.
John FultonBrown School of Public Health, Providence, RI, USA.
Min DaiChina National Cancer Center, Beijing, 100021, China.
Ni LiChina National Cancer Center, Beijing, 100021, China.
Kunchong ShiBrown School of Public Health, Providence, RI, USA.
Zhengmin QianCollege for Public Health & Social Justice Saint Louis University, MO, USA.
Peter BoyleInternational Prevention Research Institute, Lyon, France.
Brown University · USCancer Genetics (United States) · USGeorge Washington University · USInternational Prevention Research Institute · FRRhode Island Department of Health · USSaint Louis University · USWest China Medical Center of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe previously observed a rapid increase in the incidence of renal cell carcinoma (RCC) in men and women between 1935 and 1989 in the USA, using data from the Connecticut Tumor Registry. This increase appeared to be largely explained by a positive cohort effect, but no population-based study has been conducted to comprehensively examine age-period-cohort effects by histologic types for the past decade.

methodsWe calculated age-adjusted and age-specific incidence rates of the two major kidney-cancer subtypes RCC and renal urothelial carcinoma, and conducted an age-period-cohort analysis of 114 138 incident cases of kidney cancer reported between 1992 and 2014 to the Surveillance, Epidemiology, and End Results programme.

resultsThe age-adjusted incidence rates of RCC have been increasing consistently in the USA among both men and women (from 12.18/100 000 in 1992-1994 to 18.35/100 000 in 2010-2014 among men; from 5.77/100 000 in 1992-1994 to 8.63/100 000 in 2010-2014 among women). Incidence rates generally increased in successive birth cohorts, with a continuing increase in rates among the younger age groups (ages 0-54 years) in both men and women and among both Whites and Blacks. These observations were confirmed by age-period-cohort modelling, which suggested an increasing birth-cohort trend for RCC beginning with 1955 birth cohorts, regardless of the assumed value for the period effect for both men and women and for Whites and Blacks.

conclusionsKnown risk factors for kidney cancer may not fully account for the observed increasing rates or the birth-cohort pattern for RCC, prompting the need for additional etiologic hypotheses (such as environmental exposures) to investigate these descriptive patterns.

Indexed as

AdolescentAdultAgedAged, 80 and overAge FactorsCarcinoma, Renal CellChildChild, PreschoolCohort EffectCohort StudiesConnecticutFemaleHumansIncidenceInfantInfant, Newborndescriptive epidemiologyRenal cell carcinomaSEER

Identifiers

PMID31317187
PMCPMC7967823
OpenAlexW2963872213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.